Digital Ally, Inc. (Nasdaq: DGLY), which develops, manufactures and
markets advanced video surveillance products for law enforcement,
homeland security and commercial applications, today announced its
operating results for 2020. An investor conference call is
scheduled for 11:15 p.m. EDT on Wednesday, March 31, 2021 (see
details below).
Highlights for the year ended December
31, 2020
● |
Total revenues increased in 2020 to $10,514,868 from $10,441,364 in
2019. The primary reason for the overall revenue increase is an
increase of $296,661 (3%), in product revenues, offset by a decline
in service and other revenue of $223,157 (8%), from 2019 levels.
Products revenues experienced an increase due to approximately
$1.65 million of revenues generated by the Company’s new ThermoVU™
and Shield™ product lines introduced to the market in 2020. Service
and other revenues declined over the prior period due to the
impacts of the Covid-19 pandemic, as travel restrictions and the
elimination of public events adversely affected our installation
and situational security revenues. |
|
|
● |
During 2020, the Company added two new lines of branded products:
(1) the ThermoVu™ which is a line of self-contained temperature
monitoring systems that provides alerts and controls facility
access when an individual’s temperature exceeds a pre-set threshold
and (2) our Shield™ disinfectants and cleansers which are for use
against viruses and bacteria. We began offering such products
beginning late in the second quarter 2020 and experienced strong
demand during the third and fourth quarters resulting in total
revenues for 2020 approximating $1.65 million. Shield™
disinfectants has been listed on the United States Environmental
Protection Agency’s List N: Disinfectants for Use Against
SARS-CoV-2, the virus that causes COVID-19. We expect continued
revenue growth from these two new product lines in future quarters
and are considering additional products to complement these new
safety product lines. We are ramping up our supply chain for both
of these new product lines, which are manufactured by
third-parties. These branded products are being offered to our
first responder customers including police, fire and paramedics.
Commercial customers such as schools, cruise lines, taxi-cab and
para transit are also be good candidates for the products, which
the Company is actively pursuing. |
|
|
● |
The Covid-19 pandemic delayed the shipment of orders throughout
2020 as police forces and governments reacted to its impact. In
general, our salesmen were unable to travel and meet with potential
customers as they normally do to demonstrate our hardware, to
promote our integrated solutions and close hardware sales.
Specifically, we were unable to ship the initial purchase orders
under a substantial contract awarded by the Director of Strategic
Procurement of a country for the expected deployment of body
cameras to its entire national police force. The contract was
expected to include up to 5,000 body cameras with our web-based
software infrastructure service over a three-year period. Contract
deliveries were suspended pending the government’s decision to
freeze the planned deployment until such time as the pandemic is
contained within its population. The initial purchase order was
expected to ship during the first quarter 2020 with follow-on
orders for the second and third quarters of 2020 and would have
made a substantial impact to our product revenues for 2020. At this
point, we are unable to forecast if and when this major project
will be restarted or how it may be modified as a result of the
pandemic. Upon completion, the original contract would have been
the largest body camera deployment in our history and the largest
contract for recurring service revenues for our web-based software
related to the body cameras. |
|
|
● |
The Company recorded a gain of $5,250,000 during the year 2020
resulting from the termination and extinguishment of all
obligations related to the Proceeds Investment Agreement (the
“PIA”). On July 20, 2020, the Company and the holder of the PIA
executed a Termination Agreement and Mutual Release (the
“Termination Agreement”). Upon payment of $1,250,000 by the Company
both parties agreed to terminate the PIA and to release each other
from any further liability thereunder. In addition, the Company
further agreed to pay the following: (a) a contingent payment in
the amount of $2,750,000 following the closing of an asset
purchase, membership interest purchase, or similar transaction
between the Company and a specified third-party (the “Purchase
Transaction”) and (b) any and all future proceeds received from
Watchguard and its successors and assigns by the Company for
WatchGuard’s use of U.S. Patent Nos. 8,781,292 and 9,253,452. For
clarity, the parties further agreed that the payment of the
contingent payment would only be due and payable upon the closing
of the specified Purchase Transaction. The Company has not
completed the Purchase Transaction as defined in the mutual
agreement and release during 2020; however, the Company is open and
willing to proceed with the purchase transaction should the parties
agree to the underlying terms. The Company continues to monitor the
likelihood of future recoveries from Watchguard and its successors
and assigns relative to WatchGuard’s use of U.S. Patent Nos.
8,781,292 and 9,253,452. |
|
|
● |
On July 2, 2020 the SEC declared the Company’s shelf registration
statement on Form S-3 effective. The Shelf Registration Statement
provides the Company with access to liquidity from the public
markets should it decide to utilize it for such purposes. The Shelf
Registration Statement allows the Company to offer and sell, from
time to time in one or more offerings, any combination of our
common stock, debt securities, debt securities convertible into
Common Stock or other securities in any combination thereof, rights
to purchase shares of Common Stock or other securities in any
combination thereof, warrants to purchase shares of Common Stock or
other securities in any combination thereof or units consisting of
Common Stock or other securities in any combination thereof having
an aggregate initial offering price not exceeding
$125,000,000. |
|
|
● |
On August 21, 2020, the Company completed the purchase of a
building which will serve as the company’s warehouse and
distribution location for its new branded temperature screening
device ThermoVU™ and its Shield™ line of disinfectant/cleanser
products. The total purchase price was $420,000 and the Company
used its available cash to close the building purchase. |
|
|
● |
We have asserted two significant patent infringement lawsuit
involving Axon and WatchGuard that have had significant impacts on
our annual results primarily due to the timing and amount of legal
fees expended on such lawsuits. We settled the WatchGuard lawsuit
in May 2019 for a total payment from WatchGuard of $6.0 million. In
June 2019 the District Court granted Axon’s Motion for Summary
Judgment, and accepted Axon’s position that it did not infringe on
our patents and dismissed the lawsuit. We appealed the District
Court’s ruling. On April 22, 2020, a three-judge panel of the
United States Court of Appeals denied our appeal and affirmed the
District Court’s previous decision to grant Axon summary judgment.
On May 22, 2020, we filed a petition for panel rehearing requesting
that we be granted a rehearing of our appeal of the U.S. District
Court’s summary judgment ruling. Furthermore, we requested that we
be given an opportunity to make our case through oral argument in
front of the three-judge panel of the Court of Appeals, all of
which was denied. The Company has abandoned its right to any
further appeals and this matter is now concluded. Our litigation
costs related to the Axon and other lawsuits has declined
substantially in 2020 compared to 2019 and previous years.
Furthermore, we believe our future results will continue to be
positively impacted form the conclusion of these legal
matters. |
|
|
● |
Our overall gross margin percentage increased to 39% in 2020
compared to 31% in 2019. The increase is attributable to the
improved manufacturing efficiencies and improved margins on newer
product lines. Our goal is to improve our margins to 60% over the
longer term based on the expected margins of our EVO-HD, DVM-800,
VuLink, FirstVU HD, ThermoVuTM, ShieldTM disinfectants and our
cloud evidence storage and management offering, if they gain
traction in the marketplace and subject to a normalizing economy in
the wake of the COVID-19 pandemic. |
|
|
● |
The COVID-19 pandemic represents a fluid situation that presents a
wide range of potential impacts of varying durations for different
global geographies, including locations where we have offices,
employees, customers, vendors and other suppliers and business
partners. Like most US-based businesses, the COVID-19 pandemic and
efforts to mitigate the same began to have impacts on our business
in March 2020. During 2020, we have observed decreases in demand
from certain customers, including primarily our law-enforcement and
commercial customers. Given the fact that our products are sold
through a variety of distribution channels, we expect our sales
will experience more volatility as a result of the changing and
less predictable operational needs of many customers as a result of
the COVID-19 pandemic. We are aware that many companies, including
many of our suppliers and customers, are reporting or predicting
negative impacts from COVID-19 on future operating results.
Although we observed significant declines in demand for our
products from certain customers during 2020, we believe that it
remains too early for us to know the exact impact COVID-19 will
have on the long-term demand for our products. We also cannot be
certain how demand may shift over time as the impacts of the
COVID-19 pandemic may go through several phases of varying severity
and duration. To date, travel restrictions and border closures have
not materially impacted our ability to obtain inventory or
manufacture or deliver products or services to customers. However,
if such restrictions become more severe, they could negatively
impact those activities in a way that would harm our business over
the long term. Travel restrictions impacting people can restrain
our ability to assist our customers and distributors as well as
impact our ability to develop new distribution channels, but at
present we do not expect these restrictions on personal travel to
be material to our business operations or financial results. We
have taken steps to restrain and monitor our operating expenses and
therefore we do not expect any such impacts to materially change
the relationship between costs and revenues. Like most companies,
we have taken a range of actions with respect to how we operate to
assure we comply with government restrictions and guidelines as
well as best practices to protect the health and well-being of our
employees and our ability to continue operating our business
effectively. To date, we have been able to operate our business
effectively using these measures and to maintain all internal
controls as documented and posted. We also have not experienced
challenges in maintaining business continuity and do not expect to
incur material expenditures to do so. However, the impacts of
COVID-19 and efforts to mitigate the same have remained
unpredictable and it remains possible that challenges may arise in
the future. |
Recent Developments
● |
On January 14, 2021, we consummated an underwritten public offering
of 2,800,000 shares of common stock and 7,200,000 prefunded
purchase warrants of common stock, both at a price of $3.095 per
share. The net proceeds, after deducting underwriting discounts and
commissions but before deducting other expenses in connection with
the offering, are approximately $29.01 million. We plan to use the
net proceeds from the Offering for working capital, product
development, order fulfillment and for general corporate purposes.
This offering was completed under the Company’s effective shelf
registration statement on Form S-3. |
|
|
● |
On February 1, 2021, we consummated an underwritten public offering
of 3,250,000 shares of common stock and 11,050,000 prefunded
purchase warrants of common stock, both at a price of $2.799 per
share. The net proceeds, after deducting underwriting discounts and
commissions but before deducting other expenses in connection with
the offering, are approximately $37.45 million. We plan to use the
net proceeds from the Offering for working capital, product
development, order fulfillment and for general corporate purposes.
This offering was completed under the Company’s effective shelf
registration statement on Form S-3. |
|
|
● |
On February 24, 2021, the Company entered into a contract to
purchase a 71,361 square foot building located in Lenexa Kansas
which is intended to serve as the Company’s office and warehouse
needs. The building contains approximately 30,000 square foot of
office space and the remainder warehouse space. The total purchase
price is approximately $5.3 million and is expected to close on or
around May 1, 2021. |
Management Comments
Stanton E. Ross, Chief Executive Officer of
Digital Ally, stated, “We are very pleased to report an increase in
total revenues together with a 74% improvement in our net loss for
2020 as compared to 2019. Importantly we were able to report
improvements in revenue and net loss regardless of the challenges
to our legacy business caused by the Covid-19 pandemic during 2020.
Our decision not to stand still during the Covid-19 pandemic and
proactively expand our product offerings to include the ThermoVU
and Shield lines has proven to be successful as they generated
approximately $1.65 million in combined revenues during the 2020.
We are considering further expansion of the ThermoVU and Shield
product lines to include complementary products that we hope they
will achieve similar market acceptance. We also reduced our
SG&A expenses (excluding the effect of the $6 million patent
litigation settlement in 2019) significantly by reducing staffing
levels, limiting travel and reducing many advertising and
promotional activities. In addition, we have improved our balance
sheet and liquidity position substantially during 2020 and in early
2021 through several public offerings. These offerings will provide
us with the flexibility to take advantage of new business
opportunities and to expand our existing business lines.to benefit
the Company and its shareholders for 2021 and beyond” concluded
Ross.
2020 Operating Results
For the year ended December 31, 2020, our total
revenue increased by 1% to approximately $10.5 million, compared
with revenue of approximately $10.4 million for the year ended
December 31, 2019.
Gross profit increased 20% to $4,062,594 for the
year ended December 31, 2020 versus $3,232,629 in 2019. Our gross
margin increase is primarily attributable to the cost of sales as
percentage of revenues decreasing to 61% for the year ended
December 31, 2020 from 69% for the year ended December 31, 2019
paired with the slight increase in total revenue for 2020.
Selling, General and Administrative (“SG&A”)
expenses increased approximately 27% to $11,726,410 in the year
ended December 31, 2020 versus $9,265,410 in 2019. The significant
increase was attributable to the patent litigation settlement of
$6.0 million that we received during 2019 that did not recur in
2020. Exclusive of such settlement, overall selling, general and
administrative expenses as a percentage of sales increased to 112%
for the year ended December 31, 2020 compared to 146% in 2019.
We reported an operating loss of $7,663,651 for
the year ended December 31, 2020, compared to an operating loss of
$6,032,781 in 2019.
We elected to account for the PIA that was
entered into July of 2018 on its fair value basis. Therefore, we
determined the fair value of the 2018 PIA as of December 31, 2020,
and December 31, 2019 to be $0 and $6,500,000, respectively. During
the year ended December 31, 2019, we settled our patent
infringement litigation with WatchGuard and received a lump sum
payment of $6.0 million as further described in Note 12. In
accordance with the terms of the PIA, we remitted the $6.0 million
as a principal payment toward our minimum return payment
obligations under the PIA. The change in fair value from December
31, 2019 to December 31, 2020 was $5,250,000, which was recognized
as a loss in the Consolidated Statement of Operations at December
31, 2020.
On May 4, 2020 the Company received a $1,418,900
promissory note under the SBA’s PPP Loan through the CARES Act. On
December 10, 2020, we were informed that the Company’s SBA Loan had
been fully forgiven, less the EIDL Advance received ($10,000), thus
the remaining balance has been released resulting in a gain on
extinguishment of debt.
We reported a net loss of ($2,625,881), or
($0.12) per share, in the year ended December 31, 2020 compared to
a prior-year net loss of ($10,005,713) or ($0.87) per share. No
income tax provision or benefit was recorded in the either 2020 or
2019 as the Company has maintained a full valuation reserve on its
deferred tax assets.
Investor Conference Call
The Company will host an investor
conference call at 11:15 p.m. EDT on Wednesday, March 31, 2021, to
discuss its operating results for 2020, developments related to its
disinfectant and safety products, the impact of the Covid-19
pandemic and other topics of interest. Shareholders and other
interested parties may participate in the conference call by
dialing 844-761-0863 and entering conference ID# 7465801 a few
minutes before 11:15 p.m. EDT on Wednesday, March 31,
2021.
A replay of the conference call will be
available two hours after its completion, from March 31, 2021 until
11:59 p.m. on April 31, 2021 by dialing 855-859-2056 and entering
the conference ID # 7465801.
For additional news and information please visit
or follow us on Twitter @digitalallyinc and Facebook
www.facebook.com/DigitalAllyInc
Follow additional Digital Ally Inc. social media
channels here:
Facebook | Instagram | LinkedIn | Twitter
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Act of 1934. These
forward-looking statements are based largely on the expectations or
forecasts of future events, can be affected by inaccurate
assumptions, and are subject to various business risks and known
and unknown uncertainties, a number of which are beyond the control
of management. Therefore, actual results could differ materially
from the forward-looking statements contained in this press
release. A wide variety of factors that may cause actual results to
differ from the forward-looking statements include, but are not
limited to, the following: whether the Company will be able to
improve its revenue and operating results, especially in light of
the adverse effects of the Covid-19 pandemic on our customers,
suppliers and employees; whether it will be able to resolve its
liquidity and operational issues given the impact of the Covid-19
pandemic; whether it will be able to achieve improved production
and other efficiencies to restore its gross and operating margins
in the future; whether the Company will be able to continue to
expand into non-law enforcement markets, including
disinfectant/sanitizer and temperature screening products, and
increase its service based revenue; whether the Company has
resolved its product quality and supply chain issues; whether the
EVO-HD will help the Company increase its product revenues; whether
the Company will continue to experience declines in legal expenses
as a result of concluding its patent litigation; whether and the
extent to which the US Patent and Trademark Office (USPTO) rulings
will curtail, eliminate or otherwise have an effect on the actions
of competitors and others in the marketplace respecting the
Company, its products and customers; its ability to deliver its
newer product offerings as scheduled, and in particular the new
EVO-HD product platform, obtain the required components and
products on a timely basis, and have them perform as planned; its
ability to maintain or expand its share of the markets in which it
competes, including those outside the law enforcement industry;
whether it will be able to adapt its technology to new and
different uses, including being able to introduce new products;
competition from larger, more established companies with far
greater economic and human resources; its ability to attract and
retain customers and quality employees; the effect of changing
economic conditions; and changes in government regulations, tax
rates and similar matters. These cautionary statements should not
be construed as exhaustive or as any admission as to the adequacy
of the Company’s disclosures. The Company cannot predict or
determine after the fact what factors would cause actual results to
differ materially from those indicated by the forward-looking
statements or other statements. The reader should consider
statements that include the words “believes,” “expects,”
“anticipates,” “intends,” “estimates,” “plans,” “projects,”
“should,” or other expressions that are predictions of or indicate
future events or trends, to be uncertain and forward-looking. It
does not undertake to publicly update or revise forward-looking
statements, whether because of new information, future events or
otherwise. Additional information respecting factors that could
materially affect the Company and its operations are contained in
its Annual Report on Form 10-K for the year ended December 31,
2020, filed with the Securities and Exchange Commission (the
“SEC”).
For Additional Information, Please
Contact:Stanton E. Ross, CEO, at (913) 814-7774
orThomas J. Heckman, CFO, at (913)
814-7774(Financial Highlights Follow)
DIGITAL ALLY,
INC.CONDENSED CONSOLIDATED BALANCE
SHEETSDECEMBER 31, 2020 AND 2019
|
|
December 31, 2020 |
|
|
December 31, 2019 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
4,361,758 |
|
|
$ |
359,685 |
|
Accounts receivable-trade, less allowance for doubtful accounts of
$123,224 – 2020 and 2019 |
|
|
1,705,461 |
|
|
|
1,071,018 |
|
Accounts receivable-other |
|
|
1,529,920 |
|
|
|
514,730 |
|
Inventories, net |
|
|
8,202,274 |
|
|
|
5,280,412 |
|
Income tax refund receivable, current |
|
|
- |
|
|
|
44,650 |
|
Prepaid expenses and other current assets |
|
|
2,030,693 |
|
|
|
381,090 |
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
17,830,106 |
|
|
|
7,651,585 |
|
|
|
|
|
|
|
|
|
|
Land, building and equipment,
net |
|
|
666,800 |
|
|
|
197,063 |
|
Intangible assets, net |
|
|
392,564 |
|
|
|
413,268 |
|
Operating lease right of use
assets, net |
|
|
753,175 |
|
|
|
122,459 |
|
Other assets |
|
|
1,154,881 |
|
|
|
532,500 |
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
20,797,527 |
|
|
$ |
8,916,875 |
|
|
|
|
|
|
|
|
|
|
Liabilities and
Stockholders’ Equity (Deficit) |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
1,144,675 |
|
|
$ |
2,339,985 |
|
Accrued expenses |
|
|
796,094 |
|
|
|
845,881 |
|
Operating lease obligations – Current |
|
|
113,484 |
|
|
|
159,160 |
|
Contract liabilities – Current |
|
|
1,647,469 |
|
|
|
1,707,943 |
|
Debt obligations – Current |
|
|
11,727 |
|
|
|
1,827,748 |
|
Income taxes payable |
|
|
7,158 |
|
|
|
5,934 |
|
Total current liabilities |
|
|
3,720,606 |
|
|
|
6,886,651 |
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
Proceeds investment agreement obligation, at fair value –
Long-term |
|
|
— |
|
|
|
6,500,000 |
|
Operating lease obligation – Long-term |
|
|
723,272 |
|
|
|
44,460 |
|
Debt obligations – Long-term |
|
|
148,272 |
|
|
|
— |
|
Contract liabilities – Long-term |
|
|
1,848,869 |
|
|
|
1,803,143 |
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
6,441,021 |
|
|
|
15,234,254 |
|
|
|
|
|
|
|
|
|
|
Commitments and
contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity
(Deficit): |
|
|
|
|
|
|
|
|
Common stock, $0.001 par value per share; 100,000,000 and
50,000,000 shares authorized, respectively; shares issued:
26,834,709 – December 31, 2020 and 12,079,095 – December 31,
2019 |
|
|
26,835 |
|
|
|
12,079 |
|
Additional paid in capital |
|
|
106,501,396 |
|
|
|
83,216,387 |
|
Treasury stock, at cost (63,518 shares) |
|
|
(2,157,225 |
) |
|
|
(2,157,226 |
) |
Accumulated deficit |
|
|
(90,014,500 |
) |
|
|
(87,388,619 |
) |
|
|
|
|
|
|
|
|
|
Total stockholders’ equity (deficit) |
|
|
14,356,506 |
|
|
|
(6,317,379 |
) |
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders’ equity (deficit) |
|
$ |
20,797,527 |
|
|
$ |
8,916,875 |
|
(FOR ADDITIONAL INFORMATION, PLEASE REFER TO THE
COMPANY’S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER
31, 2020 FILED WITH THE SEC)
DIGITAL ALLY,
INC.CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONSFOR THE YEARS
ENDEDDECEMBER 31, 2020 AND 2019
|
|
2020 |
|
|
2019 |
|
Revenue: |
|
|
|
|
|
|
|
|
Product |
|
$ |
8,029,457 |
|
|
$ |
7,732,796 |
|
Service and other |
|
|
2,485,411 |
|
|
|
2,708,568 |
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
10,514,868 |
|
|
|
10,441,364 |
|
|
|
|
|
|
|
|
|
|
Cost of revenue: |
|
|
|
|
|
|
|
|
Product |
|
|
5,739,572 |
|
|
|
6,577,347 |
|
Service and other |
|
|
712,702 |
|
|
|
631,388 |
|
|
|
|
|
|
|
|
|
|
Total cost of revenue |
|
|
6,452,274 |
|
|
|
7,208,735 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
4,062,594 |
|
|
|
3,232,629 |
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expenses: |
|
|
|
|
|
|
|
|
Research and development expense |
|
|
1,842,800 |
|
|
|
2,005,717 |
|
Selling, advertising and promotional expense |
|
|
2,607,242 |
|
|
|
3,652,434 |
|
General and administrative expense |
|
|
7,276,203 |
|
|
|
9,607,259 |
|
Patent litigation settlement |
|
|
— |
|
|
|
(6,000,000 |
) |
|
|
|
|
|
|
|
|
|
Total selling, general and
administrative expenses |
|
|
11,726,245 |
|
|
|
9,265,410 |
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(7,663,651 |
) |
|
|
(6,032,781 |
) |
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
Interest income |
|
|
47,893 |
|
|
|
37,410 |
|
Interest expense |
|
|
(342,379 |
) |
|
|
(43,373 |
) |
Change in fair value of
secured convertible notes |
|
|
(1,300,252 |
) |
|
|
(519,821 |
) |
Change in fair value of
proceeds investment agreement |
|
|
5,250,000 |
|
|
|
(3,358,000 |
) |
Gain on the extinguishment of
debt |
|
|
1,417,413 |
|
|
|
— |
|
Secured convertible notes
issuance expense |
|
|
(34,906 |
) |
|
|
(89,148 |
) |
|
|
|
|
|
|
|
|
|
Total other income
(expense) |
|
|
5,037,769 |
|
|
|
(3,972,932 |
) |
|
|
|
|
|
|
|
|
|
Loss before income tax expense
(benefit) |
|
|
(2,625,881 |
) |
|
|
(10,005,713 |
) |
Income tax expense
(benefit) |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(2,625,881 |
) |
|
$ |
(10,005,713 |
) |
|
|
|
|
|
|
|
|
|
Net loss per share
information: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.12 |
) |
|
$ |
(0.87 |
) |
Diluted |
|
$ |
(0.12 |
) |
|
$ |
(0.87 |
) |
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
|
21,603,635 |
|
|
|
11,478,618 |
|
Diluted |
|
|
21,603,635 |
|
|
|
11,478,618 |
|
(FOR ADDITIONAL INFORMATION, PLEASE REFER TO THE
COMPANY’S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER
31, 2020 FILED WITH THE SEC)
Digital Ally (NASDAQ:DGLY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Digital Ally (NASDAQ:DGLY)
Historical Stock Chart
From Apr 2023 to Apr 2024